Autolus Therapeutics (AUTL)

• Market cap: $362M
• 1 day: -2.16%
• 5 days: -11.11%
• 1 month: -12.82%
• 3 months: -41.13%
• 6 months: 15.25%
• Year to date: -48.29%
• 1 year: -61.9%
• 5 years: -87.58%
• 10 years: -94.56%
• Sector: Healthcare
• Industry: Biotechnology

About: Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.

Employees: 647